CytoDyn, Inc.

CytoDyn, Inc.

Sector: Pharmaceutical Preparations Region: WA, United States

: | OTC Markets: CYDY

Similar to: Transgene SA, United-Guardian, Inc., Sanofi

CytoDyn, Inc. is a development stage biotechnology company, which is focused on discovering and developing a class of therapeutic monoclonal antibodies to treat human immunodeficiency virus infection. The company, through its subsidiary, CytoDyn Veterinary Medicine LLC, also explores the possible application of its existing proprietary monoclonal antibody technology for the treatment of Feline Immunodeficiency Virus. CytoDyn was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.

News & Analysis

You may also be interested in: